Current management of uveal melanoma: A review
- PMID: 37076276
- DOI: 10.1111/ceo.14214
Current management of uveal melanoma: A review
Abstract
Uveal melanoma is the most frequent primary intraocular cancer in adulthood and is mostly localised to the choroid. It can be treated using radiation therapy, laser therapy, local resection and enucleation, with the best results achieved by combining these procedures. However, up to half of patients develop metastatic disease. There are no efficacious treatment methods for patients in advanced stage or with metastasis. In recent years, several novel treatment modalities aimed at improving tumour control and reducing adverse events have emerged. This review summarises current clinical treatment methods and new therapeutic perspectives for uveal melanoma.
Keywords: eye tumour; immunotherapy; metastasis; radiotherapy; uveal melanoma.
© 2023 The Authors. Clinical & Experimental Ophthalmology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Ophthalmologists.
References
REFERENCES
-
- Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. Ophthalmology. 2012;119(8):1582-1589.
-
- Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012;32(7):1363-1372.
-
- Shields CL, Kaliki S, Shah SU, Luo W, Furuta M, Shields JA. Iris melanoma: features and prognosis in 317 children and adults. J AAPOS. 2012;16(1):10-16.
-
- Oittinen HA, O'Shaughnessy M, Cullinane AB, et al. Malignant melanoma of the ciliary body presenting as extraocular metastasis in the temporalis muscle. J Clin Pathol. 2007;60(7):834-835.
-
- Toro MD, Gozzo L, Tracia L, et al. New therapeutic perspectives in the treatment of uveal melanoma: a systematic review. Biomedicine. 2021;9(10):1311.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
